Stay updated on ADXS-NEO Personalized Tumor Antigens Clinical Trial
Sign up to get notified when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.

Latest updates to the ADXS-NEO Personalized Tumor Antigens Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, indicating restricted access. The changes include the error content and site chrome, signaling an access issue rather than substantive content updates.SummaryDifference20%

- Check55 days agoChange DetectedThe Revision line was updated from v3.6.5 to v3.6.6, indicating the page now reflects a new version. This is a small version update to the study details page.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision indicator on the page updated from v3.6.4 to v3.6.5, signaling a new build of the page. There are no indicated changes to the study content or data.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a newer version of the page. This update reflects changes to the page's metadata rather than study information.SummaryDifference0.1%

Stay in the know with updates to ADXS-NEO Personalized Tumor Antigens Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.